The best example of this phenomenon is the evolution of Sharp's syndrome into RA, scleroderma or lupus, which is accompanied by loss of anti-ribonucleoprotein (RNP) antibodies and development of disease-specific autoantibodies [14]. This evidence concerns the gene RNPC3 and mixed connective tissue disease.